In this first episode of the EuCornea Independent Medical Education Series, Prof. Sotiria Palioura and Prof. Mario Nubile unpack key findings from the 2024 ESCRS Clinical Trends Survey, revealing how often surgeons actually screen for ocular surface disease (OSD).
Despite its prevalence, meibomian gland dysfunction (MGD) often slips under the radar before cataract and refractive surgery, leading to suboptimal outcomes and patient dissatisfaction. This discussion explores how integrating systematic OSD evaluation, meibomian gland assessment and patient education into daily workflows can improve surgical precision, satisfaction and safety.
Watch now and reevaluate your approach to the ocular surface…where every detail counts. Scan the QR code in the video or visit https://education.eucornea.org/ for more.
Independent medical education supported by Alcon (Gold), Tarsus (Gold).
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
